Rentabilitas dodolan miturut bathi resik Minerva Neurosciences, Inc. (NERV)

Minerva Neurosciences Corp - logo grafis emiten NERV

Minerva Neurosciences (NERV) is developing a diversified portfolio of small molecules for the treatment of CNS disorders to mitigate regulatory risks. The company's net profit margin, presented as a time series on the GURU.Markets chart, visualizes this trajectory, where 0.00 marks a new level. While the development of roluperidone aims to address social rehabilitation challenges in schizophrenia, the lack of sales is causing a steady depletion of cash reserves.

Tingkat bathi resik Minerva Neurosciences (NERV): kanggo periode 04.07.2022 - 19.11.2026

Ringkesan rincian data analitis Minerva Neurosciences Corp (NERV)

- rega saham lan prakiraan rega para ahli:
- rincian kapitalisasi pasar:
Analisis dhasar perusahaan:Minerva Neurosciences Inc - NERV
Produk asil prodhuksi Minerva Neurosciences Inc

Net margin is calculated as the ratio of net income to total revenue. This metric determines the portion of profit the business retains from every dollar earned after deducting all expenses. For Minerva Neurosciences (NERV), this figure reflects the efficiency of implementing automated bioinformatics platforms in drug discovery. The optimization of laboratory processes directly impacts operating profitability. The trend in net margin allows for a real-time assessment of the company's financial stability.

Pesaing Minerva Neurosciences (NERV)

BIIB: Margin dodolan resik|Margin resik Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Margin dodolan resik|AXSM: Tingkat bathi resik|Margin resik acadia-pharm.com (ACAD)|Margin dodolan resik Xenon Pharmaceuticals (XENE)|Margin resik Viking Therapeutics VKTX|Tingkat bathi resik SUPN|CPRX - Margin resik|Margin resik Denali Therapeutics|HRMY: Margin dodolan resik|Biohaven - Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik AMLX|Trevi Therapeutics, Inc. (TRVI) - Margin dodolan perusahaan|Rentabilitas dodolan miturut bathi resik PRAX (Praxis Medicines)|Anavex Corp - Rentabilitas dodolan resik|Margin resik CeriBell CBLL|Margin dodolan perusahaan Prothena Biosciences (PRTA)|ALEC: Rentabilitas dodolan miturut bathi resik|ANNX - Margin dodolan resik|Omeros Corp. (OMER) - Margin resik|Margin resik Neurogene Inc. (NGNE)|Rentabilitas dodolan miturut bathi resik ACIU|Margin resik VYGR|Margin resik Neumora (NMRA)|SCLX - Margin resik|Margin dodolan resik TVGN (Tevogen Bio Holdings Inc.)|Tingkat bathi resik ACOG|Cognition Therapeutics Inc. - Margin dodolan resik|IKT - Margin dodolan resik|SAVA: Margin dodolan resik|Assertio Holdings, Inc. - Tingkat bathi resik|COYA (Coya) - Margin dodolan resik|Rentabilitas dodolan resik VTGN (Vistagen Therapeutics)|Margin resik Ovid Rx (OVID)|Acumen Pharmaceuticals - Rentabilitas dodolan resik|Margin resik CervoMed, Inc. CRVO|Margin dodolan resik Alterity Therapeutics ATHE|CLNN: Rentabilitas dodolan miturut bathi resik|PEPG (pepgen.com) - Rentabilitas dodolan resik|Jupiter Neurosciences Inc (JUNS) - Margin resik|Relmada Therapeutics - Tingkat bathi resik|ANVS (Annovis Bio Inc) - Margin dodolan resik|GRCE: Tingkat bathi resik|Margin resik Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Tingkat bathi resik|Margin resik neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Margin resik|MTVA: Rentabilitas dodolan miturut bathi resik|NeurAxis, Inc (NRXS) - Rentabilitas dodolan miturut bathi resik|HSDT: Margin dodolan resik|PASG - Margin dodolan perusahaan|Margin resik Neuphoria Therapeutics, Inc.|ATHA: Tingkat bathi resik|Margin resik Addex Therapeutics Ltd (ADXN)|ALZN (Alzamend Neuro Inc.) - Tingkat bathi resik|Margin dodolan resik CYCN (cyclerion.com)|Tingkat bathi miturut bathi resik Protagenic|KTTA: Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik CRGT (cortigent.com)|ATXI: Margin dodolan resik|BCLI (BrainStorm Cell Therapeutics) - Margin resik|CARA (Cara Therapeutics Inc.) - Margin dodolan resik|Margin resik CHRO|Rentabilitas dodolan miturut bathi resik ELYM (Eliem Therapeutics)|Margin resik ITCI (Intra-Cellular Therapies Inc.)|Margin dodolan resik LBPH (Longboard Pharma)|Margin dodolan resik Marinus Pharmaceuticals Inc MRNS|NKGen Biotech Corp - Margin dodolan resik|Tingkat bathi resik NRBO (NeuroBo Pharma)|SAGE (Sage Therapeutics, Inc) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan resik SNPX|Rentabilitas dodolan miturut bathi resik TRVN|Margin resik VIGL|Margin dodolan resik WENA|Margin dodolan perusahaan Cerevel